v3.25.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 $ 52,341 $ 7 $ 595,781 $ (23,555) $ (519,892) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,923)       (32,923)  
Issuance of common stock to directors (in shares)   4,974        
Vesting of restricted stock units (in shares)   141,563        
Vesting of restricted stock units (2,862)   (2,862)      
Exercise of stock options (in shares)   43,460        
Exercise of stock options 345   345      
Repurchase of common stock (in shares)   (1,320,531)        
Repurchase of common stock (50,019)         (50,019)
Stock-based compensation expense 10,606   10,606      
Other comprehensive (loss) income 12,847     12,847    
Ending balance (in shares) at Mar. 31, 2024   72,236,232        
Ending balance at Mar. 31, 2024 (9,665) $ 7 603,870 (10,708) (552,815) (50,019)
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 52,341 $ 7 595,781 (23,555) (519,892) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (76,515)          
Ending balance (in shares) at Jun. 30, 2024   72,343,077        
Ending balance at Jun. 30, 2024 (45,658) $ 7 608,528 (11,812) (596,407) (45,974)
Beginning balance (in shares) at Mar. 31, 2024   72,236,232        
Beginning balance at Mar. 31, 2024 (9,665) $ 7 603,870 (10,708) (552,815) (50,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (43,592)       (43,592)  
Issuance of common stock to directors (in shares)   4,692        
Issuance of common stock to directors 0   (178)     178
Vesting of restricted stock units (in shares)   77,116        
Vesting of restricted stock units (1,360)   (4,279)     2,919
Exercise of stock options (in shares)   25,037        
Exercise of stock options 163   (785)     948
Stock-based compensation expense 9,900   9,900      
Other comprehensive (loss) income (1,104)     (1,104)    
Ending balance (in shares) at Jun. 30, 2024   72,343,077        
Ending balance at Jun. 30, 2024 (45,658) $ 7 608,528 (11,812) (596,407) (45,974)
Beginning balance (in shares) at Dec. 31, 2024   74,028,786        
Beginning balance at Dec. 31, 2024 (32,640) $ 7 591,281 (11,774) (612,154) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,177)       (1,177)  
Issuance of common stock to directors (in shares)   4,735        
Vesting of restricted stock units (in shares)   167,726        
Vesting of restricted stock units (3,199)   (3,199)      
Exercise of stock options (in shares)   18,953        
Exercise of stock options 190   190      
Stock-based compensation expense 8,814   8,814      
Other comprehensive (loss) income (3,733)     (3,733)    
Ending balance (in shares) at Mar. 31, 2025   74,220,200        
Ending balance at Mar. 31, 2025 (31,745) $ 7 597,086 (15,507) (613,331) 0
Beginning balance (in shares) at Dec. 31, 2024   74,028,786        
Beginning balance at Dec. 31, 2024 (32,640) $ 7 591,281 (11,774) (612,154) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (1,489)          
Ending balance (in shares) at Jun. 30, 2025 74,000,000 74,020,688        
Ending balance at Jun. 30, 2025 $ (53,741) $ 7 605,084 (35,189) (613,643) (10,000)
Beginning balance (in shares) at Mar. 31, 2025   74,220,200        
Beginning balance at Mar. 31, 2025 (31,745) $ 7 597,086 (15,507) (613,331) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (312)       (312)  
Issuance of common stock to directors (in shares)   5,686        
Vesting of restricted stock units (in shares)   77,082        
Vesting of restricted stock units (1,269)   (1,269)      
Exercise of stock options (in shares)   30,880        
Exercise of stock options 314   314      
Repurchase of common stock (in shares)   (313,160)        
Repurchase of common stock (10,000)         (10,000)
Stock-based compensation expense 8,953   8,953      
Other comprehensive (loss) income $ (19,682)     (19,682)    
Ending balance (in shares) at Jun. 30, 2025 74,000,000 74,020,688        
Ending balance at Jun. 30, 2025 $ (53,741) $ 7 $ 605,084 $ (35,189) $ (613,643) $ (10,000)